Step Therapy Criteria
Partial extract of a Step Therapy Criteria mapping: many numbered group placeholders and drug-name slots are empty; fragment includes several explicit prior‑trial (step) requirements for selected agents (aripiprazole ODT, risperidone ODT, entecavir, lamotrigine, bisphosphonates, levalbuterol, olanzapine ODT, esomeprazole magnesium, tolterodine ER).
Explicit step therapy criterion for aripiprazole ODT: generic aripiprazole immediate‑release tablet must be tried (≥30‑day supply in prior 180 days).
Prior trial required for entecavir: generic entecavir tablets must have been tried (≥30‑day supply in prior 180 days).
Bisphosphonate group: prior trial of alendronate, ibandronate, or risedronate is required before coverage.
Lamotrigine products: require prior trial of generic immediate‑release or chewable/dispersible lamotrigine (≥30‑day supply).
Levalbuterol: require prior trial of albuterol HFA or Ventolin HFA (≥30‑day supply in prior 180 days).
Olanzapine ODT: prior trial of generic olanzapine immediate‑release tablet required before coverage.
Esomeprazole magnesium: require trial of two specified generics (examples include omeprazole, pantoprazole, lansoprazole) with ≥30‑day supplies in prior 180 days.
Risperidone ODT: coverage requires prior trial of generic risperidone immediate‑release tablet (≥30‑day supply in prior 180 days).
Tolterodine tartrate ER: prior trial of one listed generic urinary antispasmodic (≥30‑day supply in prior 180 days) required.
No material change: large portion of the fragment contains numbered Step Therapy Group and Drug Names placeholders with minimal substantive criteria.
What is changing (summary)
Step therapy requirements and provider actions (explicit rules found)
Step Therapy Criteria - explicit rule present
Step Therapy Criteria - explicit rules and extracted fragmentary requirements. Each group below preserves the original logical structure and threshold (30-day supply in prior 180 days) where specified.
ARIPIPRAZOLE ODT - Step Therapy Criteria (explicit)
- Prior trial of generic aripiprazole immediate-release (IR) tablet>= 30-day supply in prior 180 days
AND logic preserved from source: generic aripiprazole IR tablet trial required before aripiprazole ODT coverage.
RISPERIDONE ODT - Step Therapy Criteria
- Prior trial of generic risperidone immediate-release (IR) tablet>= 30-day supply in prior 180 days
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.